Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,872 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Mitral valve replacement in severe pulmonary arterial hypertension.
Mubeen M, Singh AK, Agarwal SK, Pillai J, Kapoor S, Srivastava AK. Mubeen M, et al. Among authors: kapoor s. Asian Cardiovasc Thorac Ann. 2008 Jan;16(1):37-42. doi: 10.1177/021849230801600110. Asian Cardiovasc Thorac Ann. 2008. PMID: 18245704
Long-term survival and recurrence patterns in ampullary cancer.
Balachandran P, Sikora SS, Kapoor S, Krishnani N, Kumar A, Saxena R, Kapoor VK. Balachandran P, et al. Among authors: kapoor s, kapoor vk. Pancreas. 2006 May;32(4):390-5. doi: 10.1097/01.mpa.0000220864.80034.63. Pancreas. 2006. PMID: 16670621
Weiss criteria in large adrenocortical tumors: a validation study.
Jain M, Kapoor S, Mishra A, Gupta S, Agarwal A. Jain M, et al. Among authors: kapoor s. Indian J Pathol Microbiol. 2010 Apr-Jun;53(2):222-6. doi: 10.4103/0377-4929.64325. Indian J Pathol Microbiol. 2010. PMID: 20551521 Free article.
Ectopic fascioliasis in the dorsal spine: case report.
Vatsal DK, Kapoor S, Venkatesh V, Vatsal P, Husain N. Vatsal DK, et al. Among authors: kapoor s. Neurosurgery. 2006 Sep;59(3):E706-7; discussion E706-7. doi: 10.1227/01.NEU.0000230247.42067.6C. Neurosurgery. 2006. PMID: 16955027
CML-466 Asciminib Provides Durable Molecular Responses in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) With the T315I Mutation: Updated Efficacy and Safety Data From a Phase I Trial.
Hughes TP, Cortes JE, Réa D, Mauro MJ, Hochhaus A, Kim DW, Sasaki K, Lang F, Heinrich MC, Breccia M, Deininger M, Goh YT, Janssen JJWM, Talpaz M, Coutre PL, Kapoor S, Cacciatore S, Polydoros F, Agrawal N, Mahon FX. Hughes TP, et al. Among authors: kapoor s. Clin Lymphoma Myeloma Leuk. 2022 Oct;22 Suppl 2:S300. doi: 10.1016/S2152-2650(22)01388-X. Clin Lymphoma Myeloma Leuk. 2022. PMID: 36163936 Clinical Trial.
CML-423 Trial in Progress: A Phase III Study of Asciminib vs an Investigator-Selected Tyrosine Kinase Inhibitor (TKI) in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP).
Hughes TP, Cortes J, Takahashi N, Larson R, Issa GC, Bombaci F, Ramscar N, Kapoor S, Ifrah S, Hochhaus A. Hughes TP, et al. Among authors: kapoor s. Clin Lymphoma Myeloma Leuk. 2022 Oct;22 Suppl 2:S297-S298. doi: 10.1016/S2152-2650(22)01383-0. Clin Lymphoma Myeloma Leuk. 2022. PMID: 36163929 Clinical Trial.
CML-395 Efficacy and Safety Results From ASCEMBL, a Phase III Study of Asciminib vs. Bosutinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) After ≥2 Prior Tyrosine Kinase Inhibitors (TKIs): Week 96 Update.
Réa D, Hochhaus A, Mauro MJ, Minami Y, Lomaia E, Voloshin S, Turkina A, Kim DW, Apperley JF, Cortes JE, Abdo A, Fogliatto LM, Kim DDH, Coutre PL, Saussele S, Annunziata M, Hughes TP, Chaudhri N, Chee L, García-Gutiérrez V, Sasaki K, Kapoor S, Allepuz A, Quenet S, Bédoucha V, Boquimpani C. Réa D, et al. Among authors: kapoor s. Clin Lymphoma Myeloma Leuk. 2022 Oct;22 Suppl 2:S295-S296. doi: 10.1016/S2152-2650(22)01379-9. Clin Lymphoma Myeloma Leuk. 2022. PMID: 36163925 Clinical Trial.
1,872 results